Essential

Subscribe today for access to
Articles and Reports

By Tara Cepull, MA | Dec 18, 2024 | 1 min read

Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond

Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024

By Michael Schubert, PhD | Dec 18, 2024 | 1 min read

ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year

By Ron Shinkman | Mar 28, 2024 | 1 min read

The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan

By Michael Schubert, PhD | Mar 27, 2024 | 1 min read

The impending legislation that may determine Medicare lab fees from 2025 onward

By Karen Lovitch, David Gilboa | Mar 25, 2024 | 1 min read

Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.

By Michael Schubert, PhD | Mar 25, 2024 | 1 min read

Formulating queries that are compliant, informative, and effective—even in tricky situations.

By Tara Cepull, MA | Mar 25, 2024 | 1 min read

Program outlined in a recently introduced bill would test AI’s effectiveness in detecting suspect payments for diagnostic tests and DME.

By Michael Schubert, PhD | Mar 25, 2024 | 1 min read

How clinical laboratory professionals can advocate for legislative and regulatory improvements

By Rachel Muenz | Mar 25, 2024 | 1 min read

Joyce Gresko, partner at Alston & Bird, discusses the latest on PAMA and what will likely need to happen for SALSA to pass in 2024.

Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas

By Ron Shinkman | Mar 5, 2024 | 1 min read

UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.

By Ron Shinkman | Mar 5, 2024 | 1 min read

Both companies have made recent moves to diversify further.